Slawin Kevin M.

Director at BELLICUM PHARMACEUTICALS, INC

Sold, on record
$4.5M
Dollars the filings state
Form 4 sales
11
Latest Feb 7, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Jul 15, 2016 2016

    Sold 22,281 shares at $13.72 ($306k)

    Slawin Kevin M., Chief Technology Officer

    Sold 14% of holdings ($2.2M position)136,925 shares left0.9x usual sizeFiling

  2. 2 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Jul 18, 2016 +3 days

    Sold 2,719 shares at $13.99 ($38k)

    Slawin Kevin M., Chief Technology Officer

    Sold 2% of holdings ($1.9M position)134,206 shares left0.1x usual sizeFiling

  3. 3 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Jul 27, 2016 +9 days

    Sold 15,000 shares at $15.00 ($225k)

    Slawin Kevin M., Chief Technology Officer

    Sold 3.6% of holdings ($6.2M position)399,982 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale BELLICUM PHARMACEUTICALS, INCUnusual
    Aug 15, 2016 +19 days

    Sold 67,000 shares at $19.31 ($1.3M)

    Slawin Kevin M., Chief Technology Officer

    Sold 40.6% of holdings ($3.2M position)98,206 shares left3.6x usual sizeFiling

  5. 5 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Sep 20, 2016 +36 days

    Sold 4,584 shares at $20.01 ($92k)

    Slawin Kevin M., Chief Technology Officer

    Sold 4.6% of holdings ($2M position)95,564 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Sep 23, 2016 +3 days

    Sold 23,416 shares at $20.11 ($471k)

    Slawin Kevin M., Chief Technology Officer

    Sold 21.8% of holdings ($2.2M position)84,206 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Dec 15, 2016 +83 days

    Sold 30,000 shares at $15.45 ($464k)

    Slawin Kevin M., Chief Technology Officer

    Sold 8.5% of holdings ($5.5M position)324,982 shares left1.3x usual sizeFiling

  8. 8 Form 4 sale BELLICUM PHARMACEUTICALS, INCPlan not stated
    Feb 7, 2017 +54 days

    Sold 30,000 shares at $12.54 ($376k)

    Slawin Kevin M., Director

    Sold 9.2% of holdings ($4.1M position)294,982 shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Slawin Kevin M.
Source
Feb 7, 2017Feb 9, 2017BELLICUM PHARMACEUTICALS, INCDirectorForm 4 sale30,000$376k9.2%Plan not statedSEC
Dec 15, 2016Dec 19, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale30,000$464k8.5%Plan not statedSEC
Sep 23, 2016Sep 23, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale23,416$471k21.8%Plan not statedSEC
Sep 20, 2016Sep 20, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale4,584$92k4.6%Plan not statedSEC
Aug 15, 2016Aug 17, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale67,000$1.3M40.6%UnusualSEC
Jul 27, 2016Jul 29, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale15,000$225k3.6%Plan not statedSEC
Jul 18, 2016Jul 19, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale2,719$38k2.0%Plan not statedSEC
Jul 15, 2016Jul 19, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale22,281$306k14.0%Plan not statedSEC
Apr 22, 2016Apr 26, 2016BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale55,000$628k25.7%UnusualSEC
Nov 16, 2015Nov 18, 2015BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale24,000$496k11.5%Plan not statedSEC
Jul 15, 2015Jul 17, 2015BELLICUM PHARMACEUTICALS, INCChief Technology OfficerForm 4 sale6,000$120k3.6%Plan not statedSEC